Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer.

Por Shekelle, P, Coulter, I, Hardy, M L, Morton, S C, Favreau, J T, Gagne, J, Coulter, S A, Udani, J, Roth, E A, Jungvig, L K, Newberry, S, Rohr, L, Ramirez, L R
Publicado no Evid Rep Technol Assess (Summ) (2003)

Allelic loss detected on chromosomes 8, 10, and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin-embedded prostate tumors.

Por Deubler, D. A., Williams, B. J., Zhu, X. L., Steele, M. R., Rohr, L. R., Jensen, J. C., Stephenson, R. A., Changus, J. E., Miller, G. J., Becich, M. J., Brothman, A. R.
Publicado em 1997